310
Views
4
CrossRef citations to date
0
Altmetric
Articles

A split face comparative study between intradermal tranexamic acid and Erbium-YAG laser in treatment of melasma

, , , , ORCID Icon, & show all
Pages 555-559 | Received 07 May 2020, Accepted 14 May 2020, Published online: 04 Jun 2021

References

  • Ball Arefiev KL, Hantash BM. Advances in the treatment of melasma: a review of the recent literature. Dermatol Surg. 2012;38(7 Pt 1):971–984.
  • Saki N, Darayesh M, Heiran A. Comparing the efficacy of topical hydroquinone 2% vs. intradermal tranexamic acid microinjections in treating melasma: a split-face controlled trial. J Dermatol Treat. 2018;29(4):405–410.
  • Atefi N, Dalvand B, Ghassemi M, et al. Therapeutic effects of topical tranexamic acid in comparison with hydroquinone in treatment of women with melasma. Dermatol Ther (Heidelb). 2017;7(3):417–424.
  • Handel AC, Miot LD, Miot HA. Melasma: a clinical and epidemiological review. An Bras Dermatol. 2014;89(5):771–782.
  • Perper M, Eva A, Fayne ER, et al. Tranexamic acid in the treatment of melasma: a review of the literature. Am J Clin Dermatol. 2017;18(3):373–381.
  • Draelos ZD. Skin lightening preparations and the hydroquinone controversy. Dermatol Ther. 2007;20(5):308–313.
  • Schwandt A, Seeber N, Kautz G, et al. New lasers and light sources – old and new risks. J Dtsch Dermatol Ges. 2017;15(5):481–594.
  • Attwa E, Khater M, Assaf M, et al. Melasma treatment using an erbium:YAG laser: a clinical, immunohistochemical, and ultrastructural study. Int J Dermatol. 2015;54(2):235–244.
  • Abdel‐Raouf MH, Ali NG, Abdel‐Azim SA, et al. Comparative study of fractional Erbium: YAG laser vs combined therapy with topical steroid as an adjuvant treatment in melasma. J Cosmetol Dermatol. 2019;18(2):517–523.
  • Zhou LL, Baibergenova A. Melasma: systematic review of the systemic treatments. Int J Dermatol. 2017;56(9):902–908.
  • Sharma YK, Gupta A. Some other serendipitous discoveries in dermatology. Indian J Dermatol. 2016;61(1):95–96.
  • Emmett KJ, Lee A, Khiabanian H, et al. High-resolution genomic surveillance of 2014 ebolavirus using shared subclonal variants. PLoS Curr. 2015;7. DOI:https://doi.org/10.1371/currents.outbreaks.c7fd7946ba606c982668a96bcba43c90
  • Sharma R, Mahajan VK, Mehta KS, et al. Therapeutic efficacy and safety of oral tranexamic acid and that of tranexamic acid local infiltration with microinjections in patients with melasma: a comparative study Clinical and Experimental Dermatology. Clin Exp Dermatol. 2017;42(7):728–734.
  • Kim SJ, Park J-Y, Shibata T, et al. Efficacy and possible mechanisms of topical tranexamic acid in melasma. Clin Exp Dermatol. 2016;41(5):480–485.
  • Paasch U. The future of fractional lasers. Facial Plast Surg. 2016;32(3):261–268.
  • Khopkar US. Dermoscopy and trichoscopy in diseases of the brown skin – atlas and short text. Vol. 1. New Delhi: Jaypee Brothers Medical Publishers; 2014. p. 50–62.
  • Tse TW, Hui E. Tranexamic acid: an important adjuvant in the treatment of melasma. J Cosmet Dermatol. 2013;12(1):57–66.
  • Na JI, Choi SY, Yang SH, et al. Effect of tranexamic acid on melasma: a clinical trial with histological evaluation. J Eur Acad Dermatol Venereol. 2014;19(8):753–757.
  • Majid I, Haq I, Imran S, et al. Proposing melasma severity index: a new, more practical, office-based scoring system for assessing the severity of melasma. Indian J Dermatol. 2016;61(1):39–44.
  • Manjunath KG, Kiran C, Sonakshi S, et al. Melasma: through the eye of a dermoscopeInt. Int J Res Dermatol. 2016;2(4):113–117.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.